| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | United States | 2 | |
| #7 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Ohashi Takahiro | 7 |
| #2 | Tatebe Satoko | 7 |
| #3 | Miyashita Hitoshi | 7 |
| #4 | Enami Jumpei | 7 |
| #5 | Tsukada Yasukatsu | 7 |
| #6 | Yamazaki Hiroaki | 5 |
| #7 | Haruta Kazuhiko | 5 |
| #8 | Pang Peter K T | 2 |
| #9 | Lewanczuk Richard Z | 2 |
| #10 | Jie Shan | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CN110475790A | Anti- IgM/B cell surface antigen bispecific antibody | |
| CN108368509A | Improve the anti-IL-17 aptamers of blood retention | |
| EP2413929A2 | Method of treating cognitive impairment | |
| WO9325577A2 | Active component of parathyroid hypertensive factor |